Prediabetes Epidemiology Forecast 2025-2034

According to the Centers for Disease Control and Prevention (CDC), around 98 million Americans are affected by prediabetes. However, 8 out of 10 adults are not aware that they have prediabetes. It is presumed that the majority of individuals with prediabetes tend to develop diabetes subsequently.

Prediabetes Epidemiology Forecast Report Coverage

The “Prediabetes Epidemiology Forecast Report 2025-2034” offers comprehensive information on the prevalence and demographics of prediabetes. It projects the future incidence and prevalence rates of prediabetes across various populations. The study covers age, gender, and type as major determinants of the prediabetes-affected population. The report highlights patterns in the prevalence of prediabetes over time and projects future trends based on multiple variables.

The report provides a comprehensive overview of the disease, as well as historical and projected data on the epidemiology of prediabetes in the 8 major markets.

Regions Covered

• The United States
• Germany
• France
• Italy
• Spain
• The United Kingdom
• Japan
• India

Prediabetes Disease Overview

Prediabetes can be considered a warning of Type 2 diabetes, where blood sugar levels are higher than normal, but not high enough to be classified as Type 2 diabetes. Prediabetes can progress to diabetes without proper intervention. Several factors such as obesity or overweight, family history of diabetes, physical inactivity, unhealthy diet, and advanced age, can contribute to the development of prediabetes. Prediabetes usually has no clear symptoms, but some people may experience symptoms like increased thirst, fatigue, frequent urination, or blurred vision.

Prediabetes: Treatment Overview

Lifestyle changes, such as healthy eating, regular physical activity, and losing 5-10% of the body weight, are the primary treatment approach for prediabetes. Stress management is also recommended as chronic stress can affect blood sugar levels. Certain medications are prescribed if the individual is at high risk of developing type 2 diabetes. Metformin is commonly used for prediabetes treatment and works by reducing the amount of sugar produced by the liver and improving the body's sensitivity to insulin. Other alternatives include GLP-1 receptor agonists and SGLT2 inhibitors.

Epidemiology

The prediabetes epidemiology section offers information on the patient pool from history to the present as well as the projected trend for each of the 8 major markets. The publisher provides both current and predicted trends for prediabetes by examining a wide range of studies. Additionally, the report covers the diagnosed patient pool for prediabetes and their trends. The data is broken down into specific categories, such as total prevalent cases in males and females, and total diagnosed cases across different age groups and patient pools.

• An estimated 38% of the adult population in the United States has prediabetes, with around 27.2 million people (48.8%) aged 65 years or older affected by the condition.
• In England, around 1 in 9 adults are affected by prediabetes, accounting for nearly 12% of the population or 5.1 million adults.
• According to the Indian Council of Medical Research-India Diabetes (ICMR-INDIAB) a cross-sectional population-based study, approximately 101.3 million people in India are estimated to have diabetes, while an additional 136 million are in the prediabetic stage.
• A study by Liu et al. found that by 2018, approximately 28% of individuals aged 12-19 had prediabetes in the United States. The condition was more prevalent in males and people with overweight or obesity.

Country-wise Prediabetes Epidemiology

The prediabetes epidemiology data and findings from the United States, Germany, Spain, Italy, France, the United Kingdom, Japan, and India are also provided in the epidemiology section.

The epidemiology of prediabetes varies between countries owing to differences in genetic predisposition, diet, physical activity levels, healthcare access, and awareness, among others. In countries with a high intake of processed foods, sugary drinks, and high-fat diets, the prevalence of prediabetes is reported to be higher. As per the Centers for Disease Control and Prevention (CDC), approximately 98 million Americans are living with prediabetes, with about 8 in 10 adults not aware of their condition.

Scope of the Report

• The report covers a detailed analysis of signs and symptoms, causes, risk factors, pathophysiology, diagnosis, treatment options, and classification/types of prediabetes based on several factors.
• Prediabetes Epidemiology Forecast Report covers data for the eight major markets (the US, France, Germany, Italy, Spain, the UK, Japan, and India).
• The report helps to identify the patient population and the unmet needs of prediabetes are highlighted along with an assessment of the disease's risk and burden.

Key Questions Answered

• What are the key findings of prediabetes epidemiology in the 8 major markets?
• What will be the total number of patients with prediabetes across the 8 major markets during the forecast period?
• What was the country-wise prevalence of prediabetes in the 8 major markets in the historical period?
• Which country will have the highest number of prediabetes patients during the forecast period of 2025-2034?
• Which key factors would influence the shift in the patient population of prediabetes during the forecast period of 2025-2034?
• What are the currently available treatments for prediabetes?
• What are the disease risks, signs, symptoms, and unmet needs of prediabetes?

This product will be delivered within 3-5 business days.